"ARC Wilson Parke offers Allergy and Asthma, Family Medicine, Internal Medicine, Pediatrics, and on-site lab and radiology services. ARC Wilson Parke also offers Cardiology services through the Seton Heart Institute, for more information call 512-324-2708. We make health care easier with Same-Day and After Hours appointments, on-site lab, and all-night phone nurses. You can also use our self check-in kiosks to expedite the check-in process."

During the past decade, ARC Clinical Research at Wilson Parke conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ARC Clinical Research at Wilson Parke" #1 sponsor was "BioNTech SE" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "Cognoa, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ARC Clinical Research at Wilson Parke" #1 collaborator was "Pfizer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ARC Clinical Research at Wilson Parke" are "COVID-19" (2 trials), "Migraine" (2 trials), "SARS-CoV-2 Infection" (2 trials), "Autism Spectrum Disorder" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "ARC Clinical Research at Wilson Parke" in a lesser frequency.

Most popular intervention types in "ARC Clinical Research at Wilson Parke" are "Biological" (6 trials), "Other" (5 trials), "Drug" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "BNT162b2" (2 trials), "Lasmiditan" (2 trials), "BNT162b1" (1 trials) and "BNT162b2 20mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "ARC Clinical Research at Wilson Parke" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "ARC Clinical Research at Wilson Parke". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in ARC Clinical Research at Wilson Parke, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ARC Clinical Research at Wilson Parke, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".